Home › Insero Health Completes Phase I Trial Of Novel Therapy In Patients With Drug Resistant Epilepsy
 

Keywords :   


Insero Health Completes Phase I Trial Of Novel Therapy In Patients With Drug Resistant Epilepsy

2013-01-02 02:28:49| drugdiscoveryonline News Articles

Insero Health, Inc., a company developing natural compounds to address unmet medical needs in neurological disorders, today announced that it has completed a Phase Ib trial of its lead compound INS001 in patients with drug-resistant epilepsy

Tags: with health trial drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Tropical Storm Beryl Graphics
05.07Atlantic Tropical Weather Outlook
05.07Tropical Storm Beryl Public Advisory Number 28A
05.07Summary for Tropical Storm Beryl (AT2/AL022024)
05.07Still no sign of herd rebuilding
05.07Eastern North Pacific Tropical Weather Outlook
05.07Tubi and Pluto lead U.S. surge in free streaming
05.07Tubi free streaming service launches in the UK
More »